Published in Surgery on December 01, 1988
Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg (2010) 1.20
Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg (2006) 1.06
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev (2011) 0.98
Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J Surg (2012) 0.94
Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. World J Surg (2004) 0.86
Age and prognosis of papillary thyroid carcinoma: retrospective stratification into three groups. J Korean Surg Soc (2012) 0.78
Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival. BMC Cancer (2009) 0.77
Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature. Langenbecks Arch Surg (2006) 0.75
Thyroid cancer in children: report of three cases and a review of the Japanese literature. Surg Today (1997) 0.75
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med (1998) 3.98
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet (1998) 2.62
Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab (2007) 2.45
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab (2015) 2.41
Thyroid cancer after Chernobyl. Nature (1992) 2.35
Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11
Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol (1998) 2.09
Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev (2000) 2.06
Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab (1994) 2.05
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab (2004) 1.94
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study. Surgery (1999) 1.92
Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med (1989) 1.80
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer (2011) 1.78
Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med (1996) 1.77
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab (2003) 1.75
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid (2001) 1.73
Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet (1992) 1.68
Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J Clin Endocrinol Metab (1995) 1.62
Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol (2006) 1.59
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59
Fine needle aspiration cytopathology of phyllodes tumor. Differential diagnosis with fibroadenoma. Acta Cytol (1988) 1.57
Metastatic breast cancer: an updating. Biomed Pharmacother (2006) 1.56
Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid (1997) 1.56
Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J (1996) 1.56
The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab (1999) 1.56
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest (2003) 1.54
The aging thyroid. Endocr Rev (1995) 1.53
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clin Endocrinol (Oxf) (2011) 1.52
Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid (2000) 1.52
Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology (2000) 1.50
Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. Clin Endocrinol (Oxf) (1994) 1.50
Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab (2010) 1.50
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer (2009) 1.49
Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab (1994) 1.48
Nonrecurrent laryngeal nerve predicted before thyroidectomy by preoperative imaging. J Am Coll Surg (2000) 1.46
Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med (1982) 1.46
Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. Thyroid (2001) 1.45
Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab (1991) 1.45
Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. Am J Clin Pathol (1991) 1.45
Thyroid and lipid metabolism. Int J Obes Relat Metab Disord (2000) 1.42
Plasma and tissue chromogranin in patients with adrenocortical adenomas. J Endocrinol Invest (2004) 1.42
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. Int J Obes (Lond) (2011) 1.41
Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter. J Clin Endocrinol Metab (1994) 1.40
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab (1983) 1.40
Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness. Eur J Endocrinol (1996) 1.38
Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab (1990) 1.36
Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab (1979) 1.36
Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab (1996) 1.35
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res (1995) 1.33
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest (1986) 1.31
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab (2001) 1.31
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) (2007) 1.30
Endoscopic parathyroidectomy: report of an initial experience. Surgery (1998) 1.28
Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med (1998) 1.28
General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut (1998) 1.26
Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab (1997) 1.25
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab (2002) 1.25
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J Clin Endocrinol Metab (2007) 1.25
Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery (1997) 1.24
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab (2001) 1.23
Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dsfunction in apparently healthy subjects. J Endocrinol Invest (2001) 1.23
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene (2000) 1.23
Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab (1993) 1.23
Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. J Clin Endocrinol Metab (1992) 1.22
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer (2008) 1.22
Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet (1998) 1.20
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol (2006) 1.19
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery (1996) 1.17